Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system
Raffaella Franciotti1,2, Stefano Delli Pizzi1,2, Bernardo Perfetti1
1Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University and Aging Research Centre, Ce.S.I., "G. d'Annunzio" University Foundation, Chieti, Italy.
Summary
Default mode network activity differs in parkinsonisms. Multiple system atrophy and Parkinson's disease without visual hallucinations show reduced activity, while Parkinson's disease with visual hallucinations exhibits preserved default mode network function.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Default mode network (DMN) activity is crucial for understanding parkinsonisms.
- Visual hallucinations (VH) are key differentiators between Parkinson's disease (PD) and multiple system atrophy (MSA).
- Investigating DMN function in PD and MSA can elucidate the neural basis of clinical phenotypes.
Purpose of the Study:
- To compare DMN activity and connectivity in MSA versus PD.
- To explore the relationship between DMN function and the presence of VH in PD.
- To assess DMN alterations in early and severe PD stages.
Main Methods:
- Functional magnetic resonance imaging (fMRI) was used to assess DMN activity and connectivity.
- Participants included MSA patients, healthy controls, early PD patients, and severe PD patients (with and without VH).
- Cortical thickness and neuropsychological tests were also conducted.
Main Results:
- MSA showed reduced DMN activity compared to controls and PD with VH.
- PD with VH had preserved DMN activity and connectivity, higher than other groups.
- DMN connectivity was reduced in early and severe PD without VH compared to controls and PD with VH.
- Cortical thickness reductions were observed in severe PD, correlating with disease duration.
- Anxiety scores were higher in patients without VH.
Conclusions:
- DMN activity and connectivity are altered in parkinsonisms, differing based on VH presence.
- MSA and PD without VH exhibit reduced DMN function, while PD with VH shows preserved function.
- Functional brain changes, not structural ones, appear to drive these DMN differences.
Related Concept Videos
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation
45.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.0K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K


